Navigation Links
India IVF Treatment Market 2018 Outlook in New Research Report at

Dallas, Texas (PRWEB) November 17, 2013

India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer from infertility). Infertility or the inability to have children refers to a range of disorders some of which affect the male, and some the female, and contribute to childlessness in a couple. There is also something called unexplained infertility, where doctors are unable to provide a medical explanation for the couple’s inability to conceive.

In India, approximately 15%-20% of married couple s in their fertile age group, suffer from infertility and it is on the increase because of urbanization, pollution, chemical exposure, stress, competitive work environment, fast-paced lifestyles, late settlement in life, more women opting to work, increased incidence of diabetes, pelvic inflammatory diseases, etc.Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction; endoscopic surgery to correct anatomical problems; and the assisted reproductive technologies, including IUI, IVF, and ICSI (intra cytoplasmic sperm injection). Complete report available at .

India has become one of the favored destinations for infertility treatments such as IVF due to several factors including its medical expertise, state-of-the-art technology (which is at par with the best in the world), and a cost-effective health care system.

“India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India:

  •     Market Overview
  •     IVF Treatment Market Potential
  •     Total Fertility Rate Profile
  •     Emerging Trends
  •     The Assisted Reproductive Technology (Regulation) Bill 2010
  •     Competitive Landscape

Order a copy of this report at

Table of Contents
1. What is In Vitro Fertilization (IVF) Treatment?
2. India In Vitro Fertilization (IVF) Market Overview
2.1 IVF Market Potential
2.2 IVF Treatment Cycles
2.3 IVF Clinics
2.4 Unorganized & Fragmented Market
3. India Total Fertility Rate Profile
4. Emerging In Vitro Fertilization (IVF) Market Trends
4.1 India Fertility Tourism
4.2 Technological Advances in Treatment Procedures
4.3 Changing Lifestyle Effecting Fertility Profile Among Youngsters
4.4 Infertility Rate Among Indian Couples
4.5 Investment & Foreign Collaboration
5. The Assisted Reproductive Technology (Regulation) Bill 2010
5.1 Registration & Accreditation of Clinics
5.2 Who May Apply for Registration
5.3 Grant of Registration
5.4 Renewal, Suspension or Revocation of Registration
5.5 General Duties of Assisted Reproductive Technology Clinics
5.6 Duty of Assisted Reproductive Technology Clinic to Obtain Written Consent
5.7 Duty of Assisted Reproductive Technology Clinic to Keep Accurate Records
5.8 Duties of Assisted Reproductive Technology Clinics Using Gametes & Embryos
5.9 Sourcing of Gametes
5.10 Storage and Handling of Gametes Embryos
6. Competitive Landscape
6.1 Bourn Hall
6.2 Nova Pulse IVF Clinics
6.3 Morpheus ART
6.4 Moolchand Fertility Clinic
6.5 Southend Fertility and IVF Centre
6.6 Max Reproductive Medicine and Assisted Conception
6.7 Indira Infertility Clinic
6.8 Malpani Infertility Clinic
6.9 Fortis Bloom Fertility and IVF Centre
6.10 Mediwave IVF & Fertility Hospital
6.11 Oasis Centre for Reproductive Medicine
6.12 Akanksha Fertility Clinic
6.13 Hinduja IVF Centre
List of Tables
Table 3-1: India Total Fertility Rate by State, 2006-2010
List of Figures

Explore more reports on Pharmaceuticals and Related Market at

Other reports available on similar topics:
Indian In Vitro Diagnostics Market Analysis 2018 ( at: The Indian IVD market is valued at more than US$ 500 Million, and is expected to surpass US$ 1.5 Billion by 2018 growing steady at a CAGR of 20%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment.

Research Report on China Avian Influenza Vaccine Industry, 2013-2017 ( at: With the increasing living standards of Chinese people, the demand for eggs and poultry meat is growing accordingly. In China and other neighboring countries, avian influenza, especially highly pathogenic avian influenza, has not been effectively controlled yet. For example, H5N1 highly pathogenic avian influenza out broken in North Korea in May 2013. In addition, besides H5N1, H5 and H7 subtype highly pathogenic avian influenza are also possible to outbreak. Therefore, it is predicted that the scale of China avian influenza vaccine market will keep increasing and many animal healthcare enterprises will attach attention to this market.

About Us: is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceuticals industry, offers research studies on agriculture, energy and power, chemicals, consumer goods, environment, food and beverages, healthcare, medical devices and much more.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. India In Vitro Diagnostics (IVD) Market Analysis and 2018 Forecasts in New Research Report at
2. Equipment Rentals India unveils plan to supply a wide range of office equipment
3. Assignment India Launches Assignment Writing Service
4. Siddhi Yoga Launches Yoga Teacher Training in Rishikesh, India
5. PharmaLeaders: Top 10 Pharmaceutical Companies in India Benchmark Report - Competitive Analysis of the Leading Players in 2013
6. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
7. Business Forecaster and Global Futurist Jack Uldrich to Keynote Indianapolis YPO Event
8. PharmaPoint: Alzheimer’s Disease - India Drug Forecast and Market Analysis to 2022
9. Study to assess impact of health reform in India
10. Market Publishers Ltd and India Business Reports Sign Partnership Agreement
11. Nefouse & Associates to Offer Health Insurance In Indiana Through Federal Facilitated Exchange
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology: